Great science doesn't guarantee a market. Nick Sandland spent years finding that out for other people, before he bet his own career on it.
In this episode of The Plucky Bamboo Podcast, Nick Sandland, the commercial lead at Algenesis Labs, talks about what it actually takes to turn deep material science into a business. Algenesis was founded by three UC San Diego professors with a genuinely novel biodegradable polyurethane and no industry experience. Nick joined to build the commercial side from nothing, including the sales pipeline, the manufacturing logistics, and the go-to-market strategy.
Nick explains why footwear became Algenesis's wedge market instead of chasing every industry that could technically use the material, and how a research paper on microplastics, published within weeks of a major New England Journal of Medicine article, unexpectedly turned an abstract sustainability pitch into something people could feel personally.
We discuss:
Why scientific credibility and commercial viability are two separate problems
Why off-take agreements aren't the safety net most founders assume
How the funding bar for materials companies has quietly risen, and what VCs actually mean when they say no
Why relying on a single manufacturing plant is a bigger risk than founders realise
Why giving away product converts faster than any pitch deck
Nick's take is straightforward: in industrial materials, there's no way to skip the adoption curve. You win the innovators and early adopters first, and everything else follows from there.
If you're commercialising deep science in a risk-averse, long-cycle industry, this conversation is full of specific, hard-won lessons on positioning, partnerships, and what actually earns trust.